Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1948 7
1949 4
1950 3
1951 4
1952 4
1953 3
1954 2
1956 3
1957 4
1958 2
1959 1
1960 4
1961 5
1962 2
1963 2
1964 8
1965 6
1969 11
1970 13
1971 16
1972 16
1973 7
1974 16
1975 14
1976 12
1977 15
1978 20
1979 12
1980 7
1981 14
1982 11
1983 15
1984 26
1985 21
1986 25
1987 13
1988 22
1989 40
1990 33
1991 55
1992 25
1993 36
1994 17
1995 26
1996 19
1997 23
1998 28
1999 34
2000 45
2001 37
2002 41
2003 30
2004 44
2005 57
2006 51
2007 40
2008 58
2009 56
2010 57
2011 70
2012 70
2013 58
2014 72
2015 92
2016 72
2017 53
2018 66
2019 109
2020 170
2021 170
2022 186
2023 186
2024 106
2025 69
2026 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,556 results

Results by year

Filters applied: . Clear all
Page 1
Lymphopenia in sepsis: a narrative review.
Wang Z, Zhang W, Chen L, Lu X, Tu Y. Wang Z, et al. Crit Care. 2024 Sep 20;28(1):315. doi: 10.1186/s13054-024-05099-4. Crit Care. 2024. PMID: 39304908 Free PMC article. Review.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Bidard FC, Hardy-Bessard AC, Dalenc F, Bachelot T, Pierga JY, de la Motte Rouge T, Sabatier R, Dubot C, Frenel JS, Ferrero JM, Ladoire S, Levy C, Mouret-Reynier MA, Lortholary A, Grenier J, Chakiba C, Stefani L, Plaza JE, Clatot F, Teixeira L, D'Hondt V, Vegas H, Derbel O, Garnier-Tixidre C, Canon JL, Pistilli B, André F, Arnould L, Pradines A, Bièche I, Callens C, Lemonnier J, Berger F, Delaloge S; PADA-1 investigators. Bidard FC, et al. Lancet Oncol. 2022 Nov;23(11):1367-1377. doi: 10.1016/S1470-2045(22)00555-1. Epub 2022 Sep 29. Lancet Oncol. 2022. PMID: 36183733 Clinical Trial.
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Izutsu K, Makita S, Nosaka K, Yoshimitsu M, Utsunomiya A, Kusumoto S, Morishima S, Tsukasaki K, Kawamata T, Ono T, Rai S, Katsuya H, Ishikawa J, Yamada H, Kato K, Tachibana M, Kakurai Y, Adachi N, Tobinai K, Yonekura K, Ishitsuka K. Izutsu K, et al. Blood. 2023 Mar 9;141(10):1159-1168. doi: 10.1182/blood.2022016862. Blood. 2023. PMID: 36150143 Free PMC article. Clinical Trial.
Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice.
Freytag D, Giorgiutti S, Hopsomer G, Wadier N, Depauw S, Mertz P, Augé F, Carapito R, Couillin I, Korganow AS, Pala F, Bosticardo M, Notarangelo LD, Rieux-Laucat F, Riteau N, Kirstetter P, Soulas-Sprauel P. Freytag D, et al. EMBO Mol Med. 2025 Sep;17(9):2438-2461. doi: 10.1038/s44321-025-00292-6. Epub 2025 Aug 13. EMBO Mol Med. 2025. PMID: 40804163 Free PMC article.
Lymphopenia in sepsis-an acquired immunodeficiency?
Finfer S, Venkatesh B, Hotchkiss RS, Sasson SC. Finfer S, et al. Immunol Cell Biol. 2023 Jul;101(6):535-544. doi: 10.1111/imcb.12611. Epub 2022 Dec 16. Immunol Cell Biol. 2023. PMID: 36468797 Review.
2,556 results